<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="pmc-domain-id">440</journal-id><journal-id journal-id-type="pmc-domain">plosone</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>PLOS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12225868</article-id><article-id pub-id-type="pmcid-ver">PMC12225868.1</article-id><article-id pub-id-type="pmcaid">12225868</article-id><article-id pub-id-type="pmcaiid">12225868</article-id><article-id pub-id-type="pmid">40608796</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0327304</article-id><article-id pub-id-type="publisher-id">PONE-D-25-05740</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject><subj-group><subject>Cancer Chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject><subj-group><subject>Chemotherapy</subject><subj-group><subject>Cancer Chemotherapy</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Cancer Chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Cancer Chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Malignant Tumors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug Interactions</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug Therapy</subject><subj-group><subject>Chemotherapy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Dose Prediction Methods</subject><subj-group><subject>Adjustment of Dosage at Steady State</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Bifurcation study of a tumor-immune system with chemotherapy</article-title><alt-title alt-title-type="running-head">Bifurcation study of a tumor-immune system</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3443-5411</contrib-id><name name-style="western"><surname>Ajbar</surname><given-names initials="A">Abdelhamid</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Alqahtani</surname><given-names initials="RT">Rubayyi T.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Alhumaizi</surname><given-names initials="K">Khalid</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Chemical Engineering Department, College of Engineering, King Saud University, Riyadh, Saudi Arabia</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Mathematics and Statistics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia</addr-line></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>de los Reyes V</surname><given-names initials="AA">Aurelio A.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of the Philippines Diliman, PHILIPPINES</addr-line>
</aff><author-notes><corresp id="cor001">* E-mail: <email>aajbar@ksu.edu.sa</email></corresp><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>No authors have competing interests.</p></fn></author-notes><pub-date pub-type="epub"><day>3</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">491955</issue-id><elocation-id>e0327304</elocation-id><history><date date-type="received"><day>3</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>03</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-04 18:25:43.383"><day>04</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 Ajbar et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Ajbar et al</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pone.0327304.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="pone.0327304.pdf"/><abstract><p>Understanding the dynamics of cancer cell growth, the interplay between tumor and immune cells, and the efficacy of chemotherapy are pivotal areas of focus in cancer research. In this regard, mathematical modeling can provide significant insights. This study re-examines a classical two-dimensional model of tumor-immune cell interactions where the tumor&#8217;s growth rate is assumed to adhere to von Bertalanffy&#8217;s model instead of the logistic model. We investigate the model both without chemotherapy and with treatment. The equilibrium points are identified, classified, and their stability analyzed. Our results reveal that the model can demonstrate a broad spectrum of behaviors, including bi-stability and multi-stability as well as regions of stable periodic behavior. We establish analytical conditions for the existence of Hopf points. Furthermore, we assess the impact of model parameters on the various behavior predicted by the model. This mathematical investigation can provide general guidance on treatment strategies.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University</institution></funding-source><award-id>( IMSIU-DDRSP2501).</award-id><principal-award-recipient><name name-style="western"><surname>Alqahtani</surname><given-names>Rubayyi T.</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="20"/><table-count count="2"/><page-count count="24"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>1 Introduction</title><p>Cancer is still a major contributor to global mortality rates. The costs related to its treatment and management have a considerable financial impact especially on health care systems in less developed countries. According to global estimates from 2022, approximately 20 million new cases of cancer were diagnosed, resulting in close to 10 million deaths [<xref rid="pone.0327304.ref001" ref-type="bibr">1</xref>].</p><p>Extensive research efforts are in progress to discover new therapeutic options and to improve the performance of existing ones [<xref rid="pone.0327304.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0327304.ref003" ref-type="bibr">3</xref>]. A key element of this research is the integration of mathematical modeling in cancer research studies. Such modeling is important for multiple reasons including clarifying the growth behaviors of tumor cells [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>], customizing and refining treatment protocols [<xref rid="pone.0327304.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0327304.ref006" ref-type="bibr">6</xref>], investigating drug resistance [<xref rid="pone.0327304.ref007" ref-type="bibr">7</xref>], and predicting the efficacy of new therapeutic interventions [<xref rid="pone.0327304.ref008" ref-type="bibr">8</xref>].</p><p>The numerous mathematical models proposed in the literature are characterized by differences in the number of cell types considered such as NK, <inline-formula id="pone.0327304.e001"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e001g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e001.jpg"/><mml:math id="M1" display="inline" overflow="scroll"><mml:mrow><mml:mtext>CD</mml:mtext><mml:msup><mml:mn>8</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>T</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>, and <inline-formula id="pone.0327304.e002"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e002g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e002.jpg"/><mml:math id="M2" display="inline" overflow="scroll"><mml:mrow><mml:mtext>CD</mml:mtext><mml:msup><mml:mn>4</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>T</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula> cells as well as the modeling techniques used which encompass ordinary differential equations, partial differential equations, fractional order models and stochastic models [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>&#8211;<xref rid="pone.0327304.ref023" ref-type="bibr">23</xref>]. The dynamics between immune cells and cancer are commonly analogized to the interactions between predators and their preys. When activated, immune cells behave like predators, chasing after tumor cells, creating physical connections, and destroying the cells they target. An extensive examination of the similarities between tumor-immune interactions and predator-prey relationships was explored in [<xref rid="pone.0327304.ref024" ref-type="bibr">24</xref>].</p><p>The early research by Kuznetsov <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] established one of the basic mathematical frameworks for understanding the interactions between tumor cells and immune cells represented through a predator-prey model. That framework comprised two ordinary differential equations and focused on two distinct cell types: effector cells which function as the predator, and tumor cells which serve as the prey. The analysis [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] indicated the existence of parameter spaces where only one type of cell could persist, regions of bi-stability and areas where dormant tumor cells could re-activate. de Pillis <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0327304.ref012" ref-type="bibr">12</xref>] later developed and analyzed a model of tumor-immune cells interactions. The authors showed the presence of bi-stability regions between the disease-free state and a high tumor cells concentration driven by a number of mechanisms such as saddle-node and transcritical bifurcations. Alternatively, L&#243;pez <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref014" ref-type="bibr">14</xref>] proposed and studied a different tumor-immune cells model with the presence of chemotherapy, and revealed similar results to the work in [<xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0327304.ref012" ref-type="bibr">12</xref>]. On the other hand, Makhlouf <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref016" ref-type="bibr">16</xref>] simulated an ODE model that included the interactions among tumor cells, circulating lymphocytes, <inline-formula id="pone.0327304.e003"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e003g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e003.jpg"/><mml:math id="M3" display="inline" overflow="scroll"><mml:mrow><mml:mtext>CD</mml:mtext><mml:msup><mml:mn>8</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> T cells, <inline-formula id="pone.0327304.e004"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e004g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e004.jpg"/><mml:math id="M4" display="inline" overflow="scroll"><mml:mrow><mml:mtext>CD</mml:mtext><mml:msup><mml:mn>4</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> T cells, and natural killer cells, taking into account the effects of chemotherapy. Song <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref021" ref-type="bibr">21</xref>] explored the stability of a model that depicted linear interactions between tumor cells and immune cells, drawing attention to the significant contributions of natural killer cells and cytotoxic T lymphocytes in the immune surveillance system. Recently, Bashkirtseva <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>] updated the original system [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] by integrating chemotherapy treatment. The authors [<xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>] analyzed the influence of chemotherapy dose and revealed the existence of areas of periodic behavior as well as static states. A number of recent studies (e.g. [<xref rid="pone.0327304.ref018" ref-type="bibr">18</xref>]) have also investigated the stability of tumor-immune models considering the effects of monoclonal antibody-targeted chemotherapy. This treatment approach may lead to fewer side effects in comparison to conventional chemotherapy methods.</p><p>An essential element of mathematical modeling regarding the interactions between tumor cells and immune cells is the selection of the most appropriate growth rate for tumor cells. Several growth models were proposed and analyzed in the literature [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>]. These models include linear, logistic, Mendelsohn, exponential, Gompertz, Surface, and Bertalanffy models [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>]. It is generally acknowledged that the choice of growth model is dependent on the specific type of tumors. In the context of general mathematical analysis, the literature (e.g. [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0327304.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0327304.ref014" ref-type="bibr">14</xref>&#8211;<xref rid="pone.0327304.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0327304.ref021" ref-type="bibr">21</xref>]) has largely relied on the logistic growth rate. This reliance is partly due to the ease of mathematical analysis afforded by the logistic function, although it is not necessarily the most accurate representation of tumor growth [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>].</p><p>The first objective (and novelty) of the the current work is to extend the early work of Kuznetsov <italic toggle="yes">et al</italic>. [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] to the von Bertalanffy growth rate [<xref rid="pone.0327304.ref025" ref-type="bibr">25</xref>]. The von Bertalanffy model suggests that the growth is proportional to surface area and also incorporates a decline in tumor size due to cell death. It was established that this growth model offers one of the best fits for understanding tumor growth in human subjects [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0327304.ref026" ref-type="bibr">26</xref>&#8211;<xref rid="pone.0327304.ref028" ref-type="bibr">28</xref>].</p><p>The second objective of this study is to include the effects of chemotherapy in the proposed model and to examine the effect of interactions between the model biological (intrinsic) parameters and those associated with chemtoherapy on the dynamics of the model. We determine the equilibria of the model and investigate analytically and numerically bifurcation phenomena in the model. It turns out that complex and rich dynamics are uncovered, and practical diagrams are constructed to delineate the effect of the different parameters on the outcome of the treatment. As far as we know, there has been no prior research that studied specifically the dynamics of competition based on the von Bertalanffy growth rate.</p><p>The remaining sections of the paper are structured as follows. <xref rid="sec002" ref-type="sec">Sect 2</xref> introduces the model while <xref rid="sec003" ref-type="sec">Sect 3</xref> discusses the selection of model parameters. <xref rid="sec004" ref-type="sec">Sect 4</xref> encompasses the derivation and classification of equilibria. An examination of the model in the absence of chemotherapy is conducted in <xref rid="sec005" ref-type="sec">Sect 5</xref>. <xref rid="sec009" ref-type="sec">Sect 6</xref> focuses on the investigation of the model incorporating chemotherapy treatment, culminating in a discussion in the final section.</p></sec><sec id="sec002"><title>2 The mathematical model</title><p>The model put forth for tumor-immune interactions is based on the formulation described in references [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>]. It includes two classes: Class <italic toggle="yes">E</italic>, which represents the population of effector cells (predators), and Class <italic toggle="yes">T</italic> which represents the population of tumor cells (prey). The model equations are as follows:</p><disp-formula id="pone.0327304.e005"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e005g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e005.jpg"/><mml:math id="M5" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>s</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>d</mml:mi><mml:mi>E</mml:mi><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>E</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></alternatives><label>(1)</label></disp-formula><disp-formula id="pone.0327304.e006"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e006g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e006.jpg"/><mml:math id="M6" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>&#945;</mml:mi><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>&#8722;</mml:mo><mml:mi>&#946;</mml:mi><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>n</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(2)</label></disp-formula><p>The variables <inline-formula id="pone.0327304.e007"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e007g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e007.jpg"/><mml:math id="M7" display="inline" overflow="scroll"><mml:mrow><mml:mi>E</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e008"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e008g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e008.jpg"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mrow><mml:mi>T</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> represent the populations of effector cells and tumor cells, respectively. Effector cells increase at a constant growth rate of <inline-formula id="pone.0327304.e009"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e009g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e009.jpg"/><mml:math id="M9" display="inline" overflow="scroll"><mml:mrow><mml:mi>s</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and they decrease at a constant death rate of <inline-formula id="pone.0327304.e010"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e010g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e010.jpg"/><mml:math id="M10" display="inline" overflow="scroll"><mml:mrow><mml:mi>d</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. The growth of effector cells is affected by their interaction with tumor cells, following a Michaelis-Menten growth rate described by the term <inline-formula id="pone.0327304.e011"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e011g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e011.jpg"/><mml:math id="M11" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>, where <inline-formula id="pone.0327304.e012"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e012g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e012.jpg"/><mml:math id="M12" display="inline" overflow="scroll"><mml:mrow><mml:mi>p</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> indicates the maximum recruitment potential of effector cells, and <inline-formula id="pone.0327304.e013"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e013g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e013.jpg"/><mml:math id="M13" display="inline" overflow="scroll"><mml:mrow><mml:mi>g</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> denotes the steepness coefficient of the recruitment curve. Additionally, the decline in effector cells is influenced by their interactions with tumor cells at a rate of <inline-formula id="pone.0327304.e014"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e014g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e014.jpg"/><mml:math id="M14" display="inline" overflow="scroll"><mml:mrow><mml:mi>m</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>.</p><p>The growth of tumor cell populations (<xref rid="pone.0327304.e006" ref-type="disp-formula">Eq 2</xref>) is modeled using the von Bertalanffy growth model [<xref rid="pone.0327304.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0327304.ref025" ref-type="bibr">25</xref>&#8211;<xref rid="pone.0327304.ref028" ref-type="bibr">28</xref>], where the parameters <inline-formula id="pone.0327304.e015"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e015g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e015.jpg"/><mml:math id="M15" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#945;</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:msup><mml:mi>l</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e016"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e016g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e016.jpg"/><mml:math id="M16" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#946;</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> serve as coefficients for an isolated tumor cell population. The exponent <inline-formula id="pone.0327304.e017"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e017g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e017.jpg"/><mml:math id="M17" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> indicates that the growth is proportional to the surface area, which correlates to volume raised to the power of <inline-formula id="pone.0327304.e018"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e018g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e018.jpg"/><mml:math id="M18" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. Additionally, the energy required for maintenance is directly proportional to the cell count and is represented by <inline-formula id="pone.0327304.e019"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e019g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e019.jpg"/><mml:math id="M19" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#946;</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>. Reduction of tumor cells by immune cells is carried out at a rate of <inline-formula id="pone.0327304.e020"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e020g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e020.jpg"/><mml:math id="M20" display="inline" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>.</p><p>The effect of chemotherapy on both cells is given by the non-linear terms <inline-formula id="pone.0327304.e021"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e021g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e021.jpg"/><mml:math id="M21" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>E</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e022"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e022g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e022.jpg"/><mml:math id="M22" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>, expressions inspired by the work in [<xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>]. The term <inline-formula id="pone.0327304.e023"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e023g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e023.jpg"/><mml:math id="M23" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mi>A</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> represented the daily dose of drug, where <italic toggle="yes">BSA</italic>(<italic toggle="yes">m</italic><sup>2</sup>) indicates the body surface area. The BSA method of dosing is commonly used in oncology to calculate drug dosages, as it provides a more accurate dosing than weight-based methods. The parameter <inline-formula id="pone.0327304.e024"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e024g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e024.jpg"/><mml:math id="M24" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> denotes the fractional effector cells kill by chemotherapy while <inline-formula id="pone.0327304.e025"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e025g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e025.jpg"/><mml:math id="M25" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> denotes the same for tumor cells. The terms <inline-formula id="pone.0327304.e026"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e026g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e026.jpg"/><mml:math id="M26" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:msup><mml:mi>l</mml:mi><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e027"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e027g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e027.jpg"/><mml:math id="M27" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:msup><mml:mi>l</mml:mi><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> act as constants for the fractional kill curves. For very small values of cells, <italic toggle="yes">E</italic> and <italic toggle="yes">T</italic>, the the kill rates are nearly linear but saturate if the populations of cells grow [<xref rid="pone.0327304.ref029" ref-type="bibr">29</xref>].</p><p>The model is made dimensionless by employing the following variables:</p><disp-formula id="pone.0327304.e028"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e028g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e028.jpg"/><mml:math id="M28" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mrow><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>t</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:mover><mml:mi>s</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>p</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>g</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>m</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(3)</label></disp-formula><disp-formula id="pone.0327304.e029"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e029g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e029.jpg"/><mml:math id="M29" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mover><mml:mi>&#945;</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#945;</mml:mi><mml:msubsup><mml:mi>T</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mover><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mover><mml:mi>k</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mi>E</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:msub><mml:mover><mml:mi>k</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mi>T</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mover><mml:mi>h</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>E</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mover><mml:mi>h</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(4)</label></disp-formula><p>Where <italic toggle="yes">T</italic><sub>0</sub>, <italic toggle="yes">E</italic><sub>0</sub> and <inline-formula id="pone.0327304.e030"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e030g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e030.jpg"/><mml:math id="M30" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> are reference values for <italic toggle="yes">T</italic>, <italic toggle="yes">E</italic> and <italic toggle="yes">v</italic> respectively.</p><p>The dimensionless model becomes:</p><disp-formula id="pone.0327304.e031"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e031g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e031.jpg"/><mml:math id="M31" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mover><mml:mi>t</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mover><mml:mi>s</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mover><mml:mi>p</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mover><mml:mi>g</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>+</mml:mo><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mover><mml:mi>m</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>&#8722;</mml:mo><mml:mover><mml:mi>d</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mover><mml:mi>k</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mi>E</mml:mi></mml:msub><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mover><mml:mi>h</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mn>1</mml:mn></mml:msub><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></alternatives><label>(5)</label></disp-formula><disp-formula id="pone.0327304.e032"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e032g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e032.jpg"/><mml:math id="M32" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mover><mml:mi>t</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mover><mml:mi>&#945;</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:msup><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>&#8722;</mml:mo><mml:mover><mml:mi>&#946;</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>&#8722;</mml:mo><mml:mover><mml:mi>E</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mover><mml:mi>k</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mi>T</mml:mi></mml:msub><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mover><mml:mi>v</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mover><mml:mi>h</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover><mml:mn>2</mml:mn></mml:msub><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="true">&#175;</mml:mo></mml:mover></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(6)</label></disp-formula><p>In the rest of this manuscript we drop the (<italic toggle="yes">bar</italic>) notation from all variables and parameters.</p></sec><sec id="sec003"><title>3 Model baseline parameters</title><p>The values of model parameters used for numerical simulations were carefully selected to reflect real situations and are shown in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. The parameters <inline-formula id="pone.0327304.e058"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e058g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e058.jpg"/><mml:math id="M33" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e059"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e059g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e059.jpg"/><mml:math id="M34" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> of tumor growth rate correspond to the normal growth of the tumor in the absence of an immune response. The experimental data correspond to the growth of BCL<sub>1</sub> tumor in the spleens of chimeric mice as reported in [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>]. <xref rid="pone.0327304.g001" ref-type="fig">Fig 1</xref> shows the fitting of the data using the von Bertalanffy model. The fitting, carried out using the optimization code fmincon of MATLAB [<xref rid="pone.0327304.ref030" ref-type="bibr">30</xref>], yields values of <inline-formula id="pone.0327304.e060"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e060g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e060.jpg"/><mml:math id="M35" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#945;</mml:mi><mml:mo>=</mml:mo><mml:mn>51.55</mml:mn><mml:mtext>&#160;</mml:mtext><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:msup><mml:mi>l</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0327304.e061"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e061g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e061.jpg"/><mml:math id="M36" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#946;</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0363</mml:mn><mml:mtext>&#160;</mml:mtext><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>.</p><fig position="float" id="pone.0327304.g001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g001</object-id><label>Fig 1</label><caption><title>Fitting of tumor growth parameters (blue line) with data (cross point) for growth of BCL<sub>1</sub> tumor in the spleens of chimeric mice [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>].</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g001.jpg"/></fig><table-wrap position="float" id="pone.0327304.t001" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.t001</object-id><label>Table 1</label><caption><title>Model baseline parameters [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>&#8211;<xref rid="pone.0327304.ref013" ref-type="bibr">13</xref>].</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.t001g" position="float" orientation="portrait" xlink:href="pone.0327304.t001.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">Definition</th><th align="left" rowspan="1" colspan="1">Value</th><th align="left" rowspan="1" colspan="1">Unit</th><th align="left" rowspan="1" colspan="1">Dimensionless Value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">d</italic>
</td><td align="left" rowspan="1" colspan="1">Rate of natural demise of effector cells</td><td align="left" rowspan="1" colspan="1">0.0517</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e033">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e033g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e033.jpg"/><mml:math id="M37" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">0.470</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">g</italic>
</td><td align="left" rowspan="1" colspan="1">Steepness coefficient of the recruitment curve of effector immune cells</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e034">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e034g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e034.jpg"/><mml:math id="M38" display="inline" overflow="scroll"><mml:mrow><mml:mn>2.02</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">cell</italic>
</td><td align="left" rowspan="1" colspan="1">20.2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">h</italic>
<sub>1</sub>
</td><td align="left" rowspan="1" colspan="1">constant for chemotherapy drug effect on effector cell</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e035">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e035g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e035.jpg"/><mml:math id="M39" display="inline" overflow="scroll"><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e036">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e036g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e036.jpg"/><mml:math id="M40" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">h</italic>
<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">constant for chemotherapy drug effect on tumor cell</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e037">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e037g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e037.jpg"/><mml:math id="M41" display="inline" overflow="scroll"><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e038">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e038g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e038.jpg"/><mml:math id="M42" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">k</italic>
<sub>
<italic toggle="yes">E</italic>
</sub>
</td><td align="left" rowspan="1" colspan="1">Fractional effector cells kill by chemotherapy</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e039">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e039g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e039.jpg"/><mml:math id="M43" display="inline" overflow="scroll"><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e040">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e040g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e040.jpg"/><mml:math id="M44" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">k</italic>
<sub>
<italic toggle="yes">T</italic>
</sub>
</td><td align="left" rowspan="1" colspan="1">Fractional effector cells kill by chemotherapy</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e041">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e041g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e041.jpg"/><mml:math id="M45" display="inline" overflow="scroll"><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e042">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e042g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e042.jpg"/><mml:math id="M46" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">m</italic>
</td><td align="left" rowspan="1" colspan="1">Degree of inactivation of effector cells by tumor cells</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e043">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e043g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e043.jpg"/><mml:math id="M47" display="inline" overflow="scroll"><mml:mrow><mml:mn>3.3</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>11</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e044">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e044g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e044.jpg"/><mml:math id="M48" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e045">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e045g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e045.jpg"/><mml:math id="M49" display="inline" overflow="scroll"><mml:mrow><mml:mn>3</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>
</td><td align="left" rowspan="1" colspan="1">Parameter of cancer cleanup</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e046">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e046g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e046.jpg"/><mml:math id="M50" display="inline" overflow="scroll"><mml:mrow><mml:mn>1.1</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e047">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e047g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e047.jpg"/><mml:math id="M51" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</td><td align="left" rowspan="1" colspan="1">Degree of recruitment of maximum immune-effector cells in relation with cancer cells</td><td align="left" rowspan="1" colspan="1">0.1397</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e048">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e048g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e048.jpg"/><mml:math id="M52" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">1.27</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">s</italic>
</td><td align="left" rowspan="1" colspan="1">Growth rate of effector cells</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e049">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e049g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e049.jpg"/><mml:math id="M53" display="inline" overflow="scroll"><mml:mrow><mml:mn>1.21</mml:mn><mml:mi>&#215;</mml:mi><mml:msup><mml:mn>10</mml:mn><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e050">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e050g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e050.jpg"/><mml:math id="M54" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">v</italic>
</td><td align="left" rowspan="1" colspan="1">Effect of chemotherapy drugs on tumor</td><td align="left" rowspan="1" colspan="1">1.65</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e051">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e051g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e051.jpg"/><mml:math id="M55" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">E</italic>
<sub>0</sub>
</td><td align="left" rowspan="1" colspan="1">Base value for concentration of effector cells</td><td align="left" rowspan="1" colspan="1">10<sup>6</sup></td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">cell</italic>
</td><td align="left" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">T</italic>
<sub>0</sub>
</td><td align="left" rowspan="1" colspan="1">Base value for concentration of tumor cells</td><td align="left" rowspan="1" colspan="1">10<sup>6</sup></td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">cell</italic>
</td><td align="left" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e052">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e052g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e052.jpg"/><mml:math id="M56" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">Base value for drug dose</td><td align="left" rowspan="1" colspan="1">10<sup>3</sup></td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e053">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e053g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e053.jpg"/><mml:math id="M57" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e054">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e054g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e054.jpg"/><mml:math id="M58" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">Parameter of the growth model</td><td align="left" rowspan="1" colspan="1">51.55</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e055">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e055g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e055.jpg"/><mml:math id="M59" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:msup><mml:mi>l</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">5.10</td></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e056">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e056g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e056.jpg"/><mml:math id="M60" display="inline" overflow="scroll"><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">Parameter of the growth model</td><td align="left" rowspan="1" colspan="1">0.0363</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e057">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e057g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e057.jpg"/><mml:math id="M61" display="inline" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">0.33</td></tr></tbody></table></alternatives></table-wrap><p>The other model biological parameters (<italic toggle="yes">s</italic>,<italic toggle="yes">p</italic>,<italic toggle="yes">g</italic>,<italic toggle="yes">d</italic>,<italic toggle="yes">m</italic>,<italic toggle="yes">n</italic>) and the reference values <inline-formula id="pone.0327304.e062"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e062g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e062.jpg"/><mml:math id="M62" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> were also chosen to correspond to realistic ranges. We used most of the baseline parameter values reported in [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>&#8211;<xref rid="pone.0327304.ref013" ref-type="bibr">13</xref>].</p><p>As to the chemotherapy related parameters, values of chemotherapy drug dose <italic toggle="yes">v</italic> were varied in our numerical study. The literature indicates a wide range of variations from 0.0001 <inline-formula id="pone.0327304.e063"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e063g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e063.jpg"/><mml:math id="M63" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> to daily doses of thousands of <inline-formula id="pone.0327304.e064"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e064g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e064.jpg"/><mml:math id="M64" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> [<xref rid="pone.0327304.ref031" ref-type="bibr">31</xref>]. We have selected a base value of <inline-formula id="pone.0327304.e065"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e065g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e065.jpg"/><mml:math id="M65" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>v</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mn>3</mml:mn></mml:msup><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. The rest of the chemotherapy related parameters are difficult to estimate. Base values of <italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub> and <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub> were taken to be 0.55 and 0.033 respectively as inspired from similar parameters reported in [<xref rid="pone.0327304.ref016" ref-type="bibr">16</xref>]. It should be noted that values of <italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub> are normally smaller than <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>.</p><p>Moreover, the usefulness of the dimensionless model is to allow for a sensitivity analysis of the model parameters, especially for the chemotherapy-related ones. It can be seen that the parameter (<italic toggle="yes">n</italic>) representing the rate of tumor destruction by immune cells (Eq 2) was used to render the model parameters dimensionless. This parameter vary in the literature from 10<sup>&#8722;7</sup> to <inline-formula id="pone.0327304.e066"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e066g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e066.jpg"/><mml:math id="M66" display="inline" overflow="scroll"><mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>&#8211;<xref rid="pone.0327304.ref014" ref-type="bibr">14</xref>]. It can be concluded from (<xref rid="pone.0327304.e028" ref-type="disp-formula">Eqs 3</xref>&#8211;<xref rid="pone.0327304.e029" ref-type="disp-formula">4</xref>) that the dimensionless parameters <inline-formula id="pone.0327304.e067"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e067g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e067.jpg"/><mml:math id="M67" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> can be varied over a wide range which allow for a meaningful sensitivity analysis. As for the parameters <italic toggle="yes">h</italic><sub>1</sub> and <italic toggle="yes">h</italic><sub>2</sub>, because of limited knowledge about their values their dimensionless values are varied over a wide range.</p></sec><sec id="sec004"><title>4 Equilibria existence and classification</title><p>In the following, we investigate the existence of non-trivial positive equilibria of the model (<xref rid="pone.0327304.e031" ref-type="disp-formula">Eqs 5</xref>&#8211;<xref rid="pone.0327304.e032" ref-type="disp-formula">6</xref>). Solving for the second <xref rid="pone.0327304.e032" ref-type="disp-formula">Eq 6</xref> yields</p><disp-formula id="pone.0327304.e068"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e068g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e068.jpg"/><mml:math id="M68" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#945;</mml:mi><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>&#8722;</mml:mo><mml:mi>&#946;</mml:mi><mml:mi>T</mml:mi><mml:mo>+</mml:mo><mml:mi>&#945;</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>5</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>&#8722;</mml:mo><mml:mi>&#946;</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mi>T</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>T</mml:mi><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math></alternatives><label>(7)</label></disp-formula><p>Substituting <xref rid="pone.0327304.e068" ref-type="disp-formula">Eq 7</xref> in the steady state of <xref rid="pone.0327304.e031" ref-type="disp-formula">Eq 5</xref> yields the following polynomial of fourteen order:</p><disp-formula id="pone.0327304.e069"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e069g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e069.jpg"/><mml:math id="M69" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>U</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>:</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>U</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mn>4</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mn>6</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mn>7</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mn>9</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msup><mml:mspace linebreak="newline"/><mml:mspace width="1em"/><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mn>14</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mi>U</mml:mi><mml:mrow><mml:mn>14</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></alternatives><label>(8)</label></disp-formula><p>with <italic toggle="yes">U</italic>&#8201;=&#8201;<italic toggle="yes">T</italic><sup>1/3</sup>. The coefficients of the polynomial are given in <xref rid="pone.0327304.s001" ref-type="supplementary-material">Appendix A</xref>. It can be seen that other than <italic toggle="yes">a</italic><sub>0</sub> and <italic toggle="yes">a</italic><sub>12</sub> which are positive, the rest of coefficients can either be positive or negative and no obvious relations can be deduced to define their signs. According to Descartes rule of sign, the maximum number of real and positive roots can be 14. However, any meaningful solution for <italic toggle="yes">T</italic>, must also satisfy the condition <inline-formula id="pone.0327304.e070"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e070g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e070.jpg"/><mml:math id="M70" display="inline" overflow="scroll"><mml:mrow><mml:mi>E</mml:mi><mml:mo>&#8805;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. The polynomial form of the steady-state questions (<xref rid="pone.0327304.e069" ref-type="disp-formula">Eq 8</xref>) can be conveniently used to numerically solve for the steady-state solutions together with the use of Matcont package for bifurcation analysis [<xref rid="pone.0327304.ref032" ref-type="bibr">32</xref>].</p><p>In the following we start by analyzing the behavior of the model with no chemotherapy treatment.</p></sec><sec id="sec005"><title>5 Numerical simulations for the model with no chemotherapy treatment</title><p>In the absence of chemotherapy treatment <inline-formula id="pone.0327304.e071"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e071g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e071.jpg"/><mml:math id="M71" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, the model equilibria are still described by a polynomial of fourteen order (<xref rid="pone.0327304.e069" ref-type="disp-formula">Eq 8</xref>) and the results in <xref rid="pone.0327304.s001" ref-type="supplementary-material">Appendix A</xref> still apply for the maximum number ogf positive real roots.</p><sec id="sec006"><title>5.1 Phase space analysis</title><p>For the parameter values presented in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>, and <italic toggle="yes">m</italic>&#8201;=&#8201;0.002, the polynomial (<xref rid="pone.0327304.e069" ref-type="disp-formula">Eq 8</xref>) predicts three steady states in addition to the trivial solution <inline-formula id="pone.0327304.e072"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e072g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e072.jpg"/><mml:math id="M72" display="inline" overflow="scroll"><mml:mrow><mml:mi>A</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0.234</mml:mn><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. The non-trivial steady states are: <inline-formula id="pone.0327304.e073"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e073g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e073.jpg"/><mml:math id="M73" display="inline" overflow="scroll"><mml:mrow><mml:mi>B</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mn>1.994</mml:mn><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>10.56</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0327304.e074"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e074g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e074.jpg"/><mml:math id="M74" display="inline" overflow="scroll"><mml:mrow><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mn>0.285</mml:mn><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>571.64</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, and <inline-formula id="pone.0327304.e075"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e075g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e075.jpg"/><mml:math id="M75" display="inline" overflow="scroll"><mml:mrow><mml:mi>D</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0205</mml:mn><mml:mo>,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>3081.16</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. The steady state (<italic toggle="yes">B</italic>), classified as a stable spiral, is characterized by relatively low concentrations of tumor cells, and is referred to as the &#8220;dormant tumor&#8221; equilibrium point. In contrast, steady state (<italic toggle="yes">D</italic>), identified as a stable node, is marked by a high concentration of tumor cells and a low level of effector cells, which corresponds to a state of relatively &#8220;uncontrolled&#8221; tumor growth. Steady state (<italic toggle="yes">C</italic>), a saddle point has tumor cell levels situated between those of (<italic toggle="yes">B</italic>) and (<italic toggle="yes">D</italic>). The phase portrait is illustrated in <xref rid="pone.0327304.g002" ref-type="fig">Fig 2</xref>, where the one-dimensional stable manifold associated with the steady state (<italic toggle="yes">C</italic>) defines the basins of attraction for each of the respective attractors. Initial conditions (i) and (ii) in <xref rid="pone.0327304.g002" ref-type="fig">Fig 2</xref> converge asymptotically towards the dormant tumor steady state (<italic toggle="yes">B</italic>), while initial conditions (iii) and (iv) allow the tumor to evade immune regulation, ultimately settling in the active steady state (<italic toggle="yes">D</italic>).</p><fig position="float" id="pone.0327304.g002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g002</object-id><label>Fig 2</label><caption><title>Phase portrait for the model with no chemotherapy v = 0 at the dimensionless parameter values in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref> and <inline-formula id="pone.0327304.e076"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e076g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e076.jpg"/><mml:math id="M76" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">m</mml:mi><mml:mo mathvariant="bold">=</mml:mo><mml:mn mathvariant="bold">0.002</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>.</title><p>Stable manifold of saddle point (C) (blue); unstable manifold of saddle point C (red); (B), (C), and (D) are steady states; initial conditions (+) for transients (&#8211;) (denoted (i (iv)).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g002.jpg"/></fig></sec><sec id="sec007"><title>5.2 Hopf points</title><p>For the possibility of existence of periodic behavior (e.g. Hopf points) in the model, the Dulac-Bendixson criterion [<xref rid="pone.0327304.ref033" ref-type="bibr">33</xref>] can be used to investigate the existence of closed orbits for model <xref rid="pone.0327304.e031" ref-type="disp-formula">Eqs 5</xref>&#8211;(<xref rid="pone.0327304.e032" ref-type="disp-formula">6</xref>).</p><p>Consider the function (<inline-formula id="pone.0327304.e077"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e077g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e077.jpg"/><mml:math id="M77" display="inline" overflow="scroll"><mml:mrow><mml:mi>M</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></inline-formula>) and evaluate:</p><disp-formula id="pone.0327304.e078"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e078g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e078.jpg"/><mml:math id="M78" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>:</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>&#8706;</mml:mo></mml:mrow><mml:mrow><mml:mo>&#8706;</mml:mo><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo>&#8706;</mml:mo></mml:mrow><mml:mrow><mml:mo>&#8706;</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(9)</label></disp-formula><p>We have:</p><disp-formula id="pone.0327304.e079"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e079g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e079.jpg"/><mml:math id="M79" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(10)</label></disp-formula><p>therefore</p><disp-formula id="pone.0327304.e080"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e080g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e080.jpg"/><mml:math id="M80" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo>&#8706;</mml:mo></mml:mrow><mml:mrow><mml:mo>&#8706;</mml:mo><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(11)</label></disp-formula><p>and</p><disp-formula id="pone.0327304.e081"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e081g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e081.jpg"/><mml:math id="M81" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(12)</label></disp-formula><p>therefore</p><disp-formula id="pone.0327304.e082"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e082g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e082.jpg"/><mml:math id="M82" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo>&#8706;</mml:mo></mml:mrow><mml:mrow><mml:mo>&#8706;</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mi>M</mml:mi><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>E</mml:mi><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(13)</label></disp-formula><p>This yields</p><disp-formula id="pone.0327304.e083"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e083g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e083.jpg"/><mml:math id="M83" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mi>:</mml:mi><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>E</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mi>E</mml:mi><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>4</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(14)</label></disp-formula><p>One can observe that <italic toggle="yes">L</italic>&lt;0 for positive values of <italic toggle="yes">E</italic>, <italic toggle="yes">T</italic>, and the model parameters. As a result, the Dulac-Bendixson criterion is met, which implies that Hopf bifurcations resulting in limit cycles are not possible.</p><p>We can go further and even prove a stronger result (as outlined in <xref rid="pone.0327304.s002" ref-type="supplementary-material">Appendix B</xref>): this competition model is unable to predict periodic behavior for all common tumor growth models referenced in the literature, including Mendelsohn, linear, surface, and Gompertz models. Furthermore, the logistic function has been previously analyzed in [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] and has been confirmed to lack the ability to demonstrate periodic behavior.</p></sec><sec id="sec008"><title>5.3 Bifurcation analysis</title><p>We proceed to conduct a bifurcation analysis, selecting (<italic toggle="yes">m</italic>) as the bifurcation parameter. This parameter represents the rate at which effector cells are rendered inactive due to their interactions with tumor cells. Preliminary studies [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0327304.ref020" ref-type="bibr">20</xref>] as well as our own simulations have demonstrated the system&#8217;s sensitivity to variations in this parameter. <xref rid="pone.0327304.g003" ref-type="fig">Fig 3</xref> illustrates the bifurcation diagram, which indicates the presence of hysteresis, with two limit points identified at <italic toggle="yes">m</italic>&#8201;=&#8201;0.00112 and <italic toggle="yes">m</italic>&#8201;=&#8201;0.0124. The following regimes can be noted: for 0&lt;<italic toggle="yes">m</italic>&lt;0.00112, solutions stabilize at the dormant state regime for any initial states. Within the range of 0.00112&lt;<italic toggle="yes">m</italic>&lt;0.0124, the system exhibits a coexistence of dormant and uncontrolled tumor states. For <italic toggle="yes">m</italic>&gt;0.0124, the solutions of the system stabilize at the uncontrolled tumor regime for all initial conditions. In all the range of <italic toggle="yes">m</italic>, the tumor-free equilibrium (indicated by red dashed line) is unstable. At this point it is very much worthed to delineate the main differences of the model using the logistic growth rate studied in [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>] and the same model with the Von Bertalanffy&#8217;s growth rate studied in this paper. The tumor-free equilibrium <inline-formula id="pone.0327304.e084"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e084g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e084.jpg"/><mml:math id="M84" display="inline" overflow="scroll"><mml:mrow><mml:mi>A</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mi>s</mml:mi><mml:mo>/</mml:mo><mml:mi>d</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> is always unstable for von-Bertalanffy&#8217;s associated model for any model parameters. The reason is the term <italic toggle="yes">T</italic><sup>2/3</sup> in the growth rate for which the derivative at <italic toggle="yes">T</italic>&#8201;=&#8201;0 is not-defined, and some further analysis can show that the point is always unstable. This is not the case for logistic growth rate i.e. <italic toggle="yes">aT</italic>(1&#8211;<italic toggle="yes">bT</italic>). The tumor-free equilibrium can be unstable or stable depending on the sign of the term ((<italic toggle="yes">a</italic>&#8211;<italic toggle="yes">b</italic>)<italic toggle="yes">d</italic>&#8211;<italic toggle="yes">s</italic>) associated with the second eigenvalue of the Jacobian matrix at the tumor-free equilibrium. Details of mathematical derivations are given in <xref rid="pone.0327304.s003" ref-type="supplementary-material">Appendix C</xref>.</p><fig position="float" id="pone.0327304.g003" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g003</object-id><label>Fig 3</label><caption><title>Bifurcation diagrams for the model with no chemotherapy at the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>Solid line (stable branch); dashed line (unstable branch); dashed red line (unstable tumor-free equilibrium); LP (static limit point). (a) Variations of <italic toggle="yes">T</italic>; (b) Variations of <italic toggle="yes">E</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g003.jpg"/></fig><p>In order to illustrate this point, we take the same parameters for logistic model (<italic toggle="yes">a</italic>&#8201;=&#8201;1.636 and <inline-formula id="pone.0327304.e085"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e085g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e085.jpg"/><mml:math id="M85" display="inline" overflow="scroll"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>2.0</mml:mn><mml:mspace width="0.167em"/><mml:mrow><mml:mi>&#215;</mml:mi></mml:mrow><mml:mspace width="0.167em"/><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula>) that were used in the original work [<xref rid="pone.0327304.ref009" ref-type="bibr">9</xref>]. The rest of model parameters are taken from <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. In this case the term <inline-formula id="pone.0327304.e086"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e086g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e086.jpg"/><mml:math id="M86" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mspace width="0.167em"/><mml:mrow><mml:mo>&#8722;</mml:mo></mml:mrow><mml:mspace width="0.167em"/><mml:mi>b</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>d</mml:mi><mml:mspace width="0.167em"/><mml:mrow><mml:mo>&#8722;</mml:mo></mml:mrow><mml:mspace width="0.167em"/><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mi>.658</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> is positive and the tumor-free equilibrium is unstable. The bifurcation diagram will have exactly the same features as the one shown in <xref rid="pone.0327304.g003" ref-type="fig">Fig 3</xref> and will not be plotted.</p><p>However, for different values of some parameters, for example for <italic toggle="yes">s</italic>&#8201;=&#8201;0.35 and <italic toggle="yes">d</italic>&#8201;=&#8201;0.15, the term <inline-formula id="pone.0327304.e087"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e087g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e087.jpg"/><mml:math id="M87" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>d</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mn>0.1049</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> is negative and the tumor-free is stable. <xref rid="pone.0327304.g004" ref-type="fig">Fig 4</xref> shows an example of such behavior. The bifurcation diagram has changed drastically. It can be seen that below the limit point, the system settles on the stable tumor-free equilibrium. Past the limit point there is coexistence of the tumor-free equilibrium with the uncontrolled tumor equilibrium. These fundamental differences will be elaborated on further in later section.</p><fig position="float" id="pone.0327304.g004" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g004</object-id><label>Fig 4</label><caption><title>Bifurcation diagrams for the model with no chemotherapy and with logistic growth rate (aT(1&#8211;bT)) with <inline-formula id="pone.0327304.e088"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e088g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e088.jpg"/><mml:math id="M88" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">a</mml:mi><mml:mspace width="0.167em"/><mml:mo mathvariant="bold">=</mml:mo><mml:mspace width="0.167em"/><mml:mn mathvariant="bold">1.636</mml:mn><mml:mo mathvariant="bold">,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mi mathvariant="bold-italic">b</mml:mi><mml:mspace width="0.167em"/><mml:mo mathvariant="bold">=</mml:mo><mml:mspace width="0.167em"/><mml:mn mathvariant="bold">2</mml:mn><mml:mspace width="0.167em"/><mml:mi mathvariant="bold-italic">&#215;</mml:mi><mml:mspace width="0.167em"/><mml:msup><mml:mn mathvariant="bold">10</mml:mn><mml:mrow><mml:mo mathvariant="bold">&#8722;</mml:mo><mml:mn mathvariant="bold">3</mml:mn></mml:mrow></mml:msup><mml:mo mathvariant="bold">,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mspace width="0.167em"/><mml:mo mathvariant="bold">=</mml:mo><mml:mspace width="0.167em"/><mml:mn mathvariant="bold">0.35</mml:mn><mml:mo mathvariant="bold">,</mml:mo><mml:mtext>&#160;</mml:mtext><mml:mi mathvariant="bold-italic">d</mml:mi><mml:mspace width="0.167em"/><mml:mo mathvariant="bold">=</mml:mo><mml:mspace width="0.167em"/><mml:mn mathvariant="bold">0.15</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> and the rest of dimensionless parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>solid line (stable branch); dashed line (unstable branch); solid red line (stable tumor-free equilibrium); LP (static limit point).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g004.jpg"/></fig><p>Going back to <xref rid="pone.0327304.g003" ref-type="fig">Fig 3</xref> and in order to gain a deeper insight into its behavior, we delineate the various behavioral regions as function of key model parameters (<xref rid="pone.0327304.g005" ref-type="fig">Fig 5</xref>). Each branch depicted in <xref rid="pone.0327304.g005" ref-type="fig">Fig 5</xref> represents a limit point, and a hysteresis phenomenon is anticipated between the two branches. <xref rid="pone.0327304.g005" ref-type="fig">Fig 5a</xref> illustrates the impact of the effector growth rate (<italic toggle="yes">s</italic>). The two branches converge at negative values of both (<italic toggle="yes">s</italic>) and (<italic toggle="yes">m</italic>). It is evident that bi-stability can occur for any growth rate (<italic toggle="yes">s</italic>). As (<italic toggle="yes">s</italic>) increases, the bi-stability increases in term of (<italic toggle="yes">m</italic>), highlighting the model&#8217;s sensitivity to tumor escape.</p><fig position="float" id="pone.0327304.g005" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g005</object-id><label>Fig 5</label><caption><title>Two parameter continuation diagrams showing the loci of the limit point of <xref rid="pone.0327304.g003" ref-type="fig">Fig 3</xref>.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g005.jpg"/></fig><p><xref rid="pone.0327304.g005" ref-type="fig">Fig 5b</xref> demonstrates the impact of the parameter <italic toggle="yes">p</italic>. We recall that <italic toggle="yes">p</italic> indicates the extent of effector cell recruitment in relation to cancer cells. The effect of <italic toggle="yes">p</italic> is comparable to the growth rate (<italic toggle="yes">s</italic>) of effector cells. However, hysteresis is only evident when <italic toggle="yes">p</italic> surpasses the critical point linked to the cusp.</p><p>The effect of the natural death rate <italic toggle="yes">d</italic> of effector cells is presented in <xref rid="pone.0327304.g005" ref-type="fig">Fig 5c</xref>. It is observed that hysteresis takes place only for (<italic toggle="yes">d</italic>) values that are lower than the cusp. With a reduction in (<italic toggle="yes">d</italic>), bi-stability can be observed across a wide array of (<italic toggle="yes">m</italic>) which again emphasizes the system&#8217;s vulnerability to tumor escape.</p></sec></sec><sec id="sec009"><title>6 Numerical simulations for the model with chemotherapy treatment</title><p>In the following section we examine the dynamics of the model with the presence of chemotherapy (<inline-formula id="pone.0327304.e089"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e089g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e089.jpg"/><mml:math id="M89" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>&#8800;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>). We start by analyzing the possible existence of periodic behavior in the model.</p><sec id="sec010"><title>6.1 Existence of Hopf points</title><p>The elements of the Jacobian matrix are obtained by taking the derivatives of <xref rid="pone.0327304.e031" ref-type="disp-formula">Eqs 5</xref>&#8211;<xref rid="pone.0327304.e032" ref-type="disp-formula">6</xref>:</p><disp-formula id="pone.0327304.e090"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e090g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e090.jpg"/><mml:math id="M90" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mi>d</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mi>T</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(15)</label></disp-formula><disp-formula id="pone.0327304.e091"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e091g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e091.jpg"/><mml:math id="M91" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mi>E</mml:mi><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(16)</label></disp-formula><disp-formula id="pone.0327304.e092"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e092g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e092.jpg"/><mml:math id="M92" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mrow></mml:math></alternatives><label>(17)</label></disp-formula><disp-formula id="pone.0327304.e093"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e093g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e093.jpg"/><mml:math id="M93" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mi>&#946;</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>E</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#945;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:msup><mml:mi>T</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(18)</label></disp-formula><p>The existence of Hopf points [<xref rid="pone.0327304.ref033" ref-type="bibr">33</xref>] for the two dimensionless model (<xref rid="pone.0327304.e031" ref-type="disp-formula">Eqs 5</xref>&#8211;<xref rid="pone.0327304.e032" ref-type="disp-formula">6</xref>) is conditioned by:</p><disp-formula id="pone.0327304.e094"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e094g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e094.jpg"/><mml:math id="M94" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math></alternatives><label>(19)</label></disp-formula><disp-formula id="pone.0327304.e095"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e095g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e095.jpg"/><mml:math id="M95" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(20)</label></disp-formula><p>Using the steady state <xref rid="pone.0327304.e031" ref-type="disp-formula">Eq 5</xref> we can show that <italic toggle="yes">J</italic><sub><italic toggle="yes">EE</italic></sub> is reduced to</p><disp-formula id="pone.0327304.e096"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e096g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e096.jpg"/><mml:math id="M96" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(21)</label></disp-formula><p>Using the second steady state (<xref rid="pone.0327304.e032" ref-type="disp-formula">Eq 6</xref>), and dividing by <italic toggle="yes">T</italic> and eliminating <italic toggle="yes">T</italic><sup>&#8722;1/3</sup>, we can show that</p><disp-formula id="pone.0327304.e097"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e097g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e097.jpg"/><mml:math id="M97" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>h</mml:mi><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(22)</label></disp-formula><p>The first Hopf condition (<xref rid="pone.0327304.e094" ref-type="disp-formula">Eq 19</xref>) is reduced to</p><disp-formula id="pone.0327304.e098"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e098g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e098.jpg"/><mml:math id="M98" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#946;</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>v</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(23)</label></disp-formula><p>while the second condition (<xref rid="pone.0327304.e095" ref-type="disp-formula">Eq 20</xref>) is equivalent to</p><disp-formula id="pone.0327304.e099"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e099g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e099.jpg"/><mml:math id="M99" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>E</mml:mi><mml:mi>T</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>&#8722;</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>g</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>g</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>&gt;</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mo>&#8722;</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>&#946;</mml:mi><mml:mo>+</mml:mo><mml:mi>E</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(24)</label></disp-formula><p>One should note that the first three terms of <xref rid="pone.0327304.e098" ref-type="disp-formula">Eq 23</xref> are negative, implying that for <xref rid="pone.0327304.e098" ref-type="disp-formula">Eq 23</xref> to be satisfied, the condition</p><disp-formula id="pone.0327304.e100"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e100g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e100.jpg"/><mml:math id="M100" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>v</mml:mi><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives><label>(25)</label></disp-formula><p>should be satisfied. This condition is evidently not satisfied when <inline-formula id="pone.0327304.e101"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e101g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e101.jpg"/><mml:math id="M101" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>. However, for non-zero values of <italic toggle="yes">h</italic><sub>1</sub> and /or <italic toggle="yes">h</italic><sub>2</sub>, it is possible for the conditions specified in <xref rid="pone.0327304.e098" ref-type="disp-formula">Eqs 23</xref>&#8211;<xref rid="pone.0327304.e099" ref-type="disp-formula">24</xref> to be met for some model parameter values, thus not excluding the existence of Hopf points.</p></sec><sec id="sec011"><title>6.2 Bifurcation analysis</title><p>In this section, we conduct bifurcation analyses of the model. It is convenient to select the chemotherapy dose (<italic toggle="yes">v</italic>) as the bifurcation parameter. The bifurcation diagram illustrated in <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref> corresponds to the parameter values listed in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. Overall the diagram comprises an almost closed curve, with four static limit points <italic toggle="yes">LP</italic><sub>1</sub>,<italic toggle="yes">LP</italic><sub>2</sub>, <italic toggle="yes">LP</italic><sub>3</sub> and <italic toggle="yes">LP</italic><sub>4</sub>. The maximum number of steady states can be shown to be five in addition to the tumor-free equilibrium. For example, for <inline-formula id="pone.0327304.e102"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e102g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e102.jpg"/><mml:math id="M102" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0054</mml:mn></mml:mrow></mml:math></alternatives></inline-formula> we have the following steady states; (A)<inline-formula id="pone.0327304.e103"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e103g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e103.jpg"/><mml:math id="M103" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.05725</mml:mn><mml:mo>,</mml:mo><mml:mn>0.006717</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, (B)<inline-formula id="pone.0327304.e104"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e104g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e104.jpg"/><mml:math id="M104" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.06584</mml:mn><mml:mo>,</mml:mo><mml:mn>4.5217</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, (C)<inline-formula id="pone.0327304.e105"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e105g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e105.jpg"/><mml:math id="M105" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.6797</mml:mn><mml:mo>,</mml:mo><mml:mn>82.1690</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, (D)<inline-formula id="pone.0327304.e106"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e106g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e106.jpg"/><mml:math id="M106" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.3844</mml:mn><mml:mo>,</mml:mo><mml:mn>303.5360</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, and (E)<inline-formula id="pone.0327304.e107"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e107g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e107.jpg"/><mml:math id="M107" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.1143</mml:mn><mml:mo>,</mml:mo><mml:mn>1418.8600</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. (A) corresponds to very low tumor cells levels, (B) is a low tumor concentration, (C) and (D) can be considered as middle level tumor steady states while (E) is the very high tumor steady state. However, not all these equilibria are stable as can be seen in the following discussion. Going back to <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref> and in order to explain its behavior in more detail, the part indicated by a dashed rectangle in the left is enlarged in <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref> and <xref rid="pone.0327304.g007" ref-type="fig">7b</xref>. It can be seen from <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref> and <xref rid="pone.0327304.g007" ref-type="fig">7b</xref> that if the drug dose (<italic toggle="yes">v</italic>) is small and below the smallest limit point <inline-formula id="pone.0327304.e108"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e108g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e108.jpg"/><mml:math id="M108" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>;</mml:mi><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>2.295</mml:mn><mml:mspace width="0.167em"/><mml:mrow><mml:mi>&#215;</mml:mi></mml:mrow><mml:mspace width="0.167em"/><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, the tumor cells stabilize at the single steady state characterized by a relatively small tumor cells levels. When the drug dose increases past <italic toggle="yes">LP</italic><sub>1</sub>, then <xref rid="pone.0327304.g007" ref-type="fig">Fig 7b</xref> shows the existence of three steady states, indicating the existence of bi-stability between the stable very low steady state and the stable middle steady state. The enlargement of the second dashed-rectangle (on the right) of <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref>, shown in <xref rid="pone.0327304.g008" ref-type="fig">Fig 8</xref>, reveals even more complex behavior. It can be sen that the previous regime of bi-stability extends from <italic toggle="yes">LP</italic><sub>1</sub> to <italic toggle="yes">LP</italic><sub>2</sub>. However, there is the appearance of two Hopf points (<italic toggle="yes">H</italic><sub>1</sub> and <italic toggle="yes">H</italic><sub>2</sub>). Stable periodic branches (in red color) connect the two Hopf points. Therefore for values of drug dose between <italic toggle="yes">LP</italic><sub>2</sub> and <italic toggle="yes">H</italic><sub>1</sub>, three stable-steady states coexist: a very low tumor cells, a relatively low tumor cells, and the very high tumor cells levels. Different initial conditions can lead to either outcome. Between the two Hopf points, the system may settle on the very low steady state, on the very high tumor or stay on a state of oscillations. An example of such multi-stability is shown in <xref rid="pone.0327304.g009" ref-type="fig">Fig 9</xref> for for <inline-formula id="pone.0327304.e109"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e109g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e109.jpg"/><mml:math id="M109" display="inline" overflow="scroll"><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mn>5.40</mml:mn><mml:mspace width="0.167em"/><mml:mrow><mml:mi>&#215;</mml:mi></mml:mrow><mml:mspace width="0.167em"/><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> and different initial conditions. Start-up conditions <inline-formula id="pone.0327304.e110"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e110g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e110.jpg"/><mml:math id="M110" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> lead to sustained oscillations, while a small decrease in immune cells from 0.5 to 0.49, lead to high tumor cells steady state. Small initial tumor levels <inline-formula id="pone.0327304.e111"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e111g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e111.jpg"/><mml:math id="M111" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> lead, on the other hand, to the low steady-state. In the tiny stable region between <italic toggle="yes">H</italic><sub>2</sub> and <italic toggle="yes">LP</italic><sub>3</sub> (<xref rid="pone.0327304.g008" ref-type="fig">Fig 8</xref>), there is again multi-stability between the very low tumor cells, the relatively low tumor cells, and the very high tumor cells steady state. In this region between <italic toggle="yes">LP</italic><sub>3</sub> and <italic toggle="yes">LP</italic><sub>4</sub> a bi-stability coexists between the very low steady state and the very high steady state. Finally, as the drug intensity increases, the high tumor concentration decreases and any drugs dose larger than <italic toggle="yes">LP</italic><sub>4</sub> leads to the tumor demise.</p><fig position="float" id="pone.0327304.g006" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g006</object-id><label>Fig 6</label><caption><title>Bifurcation diagram for the model with chemotherapy at the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>Solid line (stable branch); dashed line (unstable branch); LP (static limit point); The dashed rectangle is enlarged in <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref> and <xref rid="pone.0327304.g007" ref-type="fig">7b</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g006.jpg"/></fig><fig position="float" id="pone.0327304.g007" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g007</object-id><label>Fig 7</label><caption><title>(a) Enlargement of the dashed rectangle in <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>; (b) Enlargement of the left dashed rectangle in <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref>.</title><p>solid line (stable branch); dashed line (unstable branch); LP (static limit point).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g007.jpg"/></fig><fig position="float" id="pone.0327304.g008" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g008</object-id><label>Fig 8</label><caption><title>Enlargement of the dashed rectangle on the right of <xref rid="pone.0327304.g007" ref-type="fig">Fig 7a</xref>;</title><p>solid line (stable branch); dashed line (unstable branch); red color (stable periodic branch); LP (static limit point); H (Hopf point).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g008.jpg"/></fig><fig position="float" id="pone.0327304.g009" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g009</object-id><label>Fig 9</label><caption><title>Simulations showing multi-stablity in <xref rid="pone.0327304.g008" ref-type="fig">Fig 8</xref> at <inline-formula id="pone.0327304.e112"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e112g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e112.jpg"/><mml:math id="M112" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mspace width="0.167em"/><mml:mo mathvariant="bold">=</mml:mo><mml:mspace width="0.167em"/><mml:mn mathvariant="bold">5.40</mml:mn><mml:mi mathvariant="bold-italic">&#215;</mml:mi><mml:msup><mml:mn mathvariant="bold">10</mml:mn><mml:mrow><mml:mo mathvariant="bold">&#8722;</mml:mo><mml:mn mathvariant="bold">3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> and different initial conditions.</title><p>(a) Start-up conditions <inline-formula id="pone.0327304.e113"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e113g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e113.jpg"/><mml:math id="M113" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> lead to sustained oscillations; (b) <inline-formula id="pone.0327304.e114"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e114g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e114.jpg"/><mml:math id="M114" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.49</mml:mn><mml:mo>,</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> lead to high tumor cells steady state. (c) <inline-formula id="pone.0327304.e115"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e115g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e115.jpg"/><mml:math id="M115" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> lead to the low steady-state.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g009.jpg"/></fig><p>Next we examine the effect of the different model parameters on the various behavior observed so far in <xref rid="pone.0327304.g006" ref-type="fig">Figs 6</xref>, <xref rid="pone.0327304.g007" ref-type="fig">7</xref>, <xref rid="pone.0327304.g008" ref-type="fig">8</xref>. This can be done by showing the loci of the limit points and the Hopf points as function of the parameters&#8217; values. The locations and crossing of the different limit and Hopf curves can give rise to additional bifurcation behavior. We focus on presenting only the results of key model parameters that have yielded bifurcation behavior other than the ones found in <xref rid="pone.0327304.g006" ref-type="fig">Figs 6</xref>, <xref rid="pone.0327304.g007" ref-type="fig">7</xref>, <xref rid="pone.0327304.g008" ref-type="fig">8</xref>.</p><p><xref rid="pone.0327304.g010" ref-type="fig">Fig 10a</xref> and <xref rid="pone.0327304.g010" ref-type="fig">10b</xref> show the effect of the fractional tumor cell kill <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>, with <xref rid="pone.0327304.g010" ref-type="fig">Fig 10b</xref> being an enlargement of <xref rid="pone.0327304.g010" ref-type="fig">Fig 10a</xref>. The solid lines indicate the loci of limit points while the red lines denote the loci of the Hopf points. It can be seen that the Hopf curve forms a minimum around <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>&#8201;=&#8201;4200 and therefore for values of <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub> smaller than the cusp, the model predicts four limit points but no Hopf points.</p><fig position="float" id="pone.0327304.g010" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g010</object-id><label>Fig 10</label><caption><title>(a) Two parameter continuation diagrams <inline-formula id="pone.0327304.e116"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e116g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e116.jpg"/><mml:math id="M116" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mo mathvariant="bold">,</mml:mo><mml:mi mathvariant="bold-italic">k</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">T</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> showing the loci of limit points (solid line) and Hopf point (red line) of <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>.</title><p>(b) Enlargement of (a).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g010.jpg"/></fig><p>An example of this behavior is shown in <xref rid="pone.0327304.g011" ref-type="fig">Fig 11a</xref> and <xref rid="pone.0327304.g011" ref-type="fig">11b</xref> for <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>&#8201;=&#8201;3000. (<xref rid="pone.0327304.g011" ref-type="fig">Fig 11b</xref> being an enlargement of <xref rid="pone.0327304.g011" ref-type="fig">Fig 11a</xref>). The same patterns seen before in <xref rid="pone.0327304.g006" ref-type="fig">Figs 6</xref>, <xref rid="pone.0327304.g007" ref-type="fig">7</xref>, <xref rid="pone.0327304.g008" ref-type="fig">8</xref> can be seen in <xref rid="pone.0327304.g011" ref-type="fig">Fig 11</xref> except the absence of a periodic behavior.</p><fig position="float" id="pone.0327304.g011" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g011</object-id><label>Fig 11</label><caption><title>(a) Bifurcation diagram for the model with chemotherapy for <inline-formula id="pone.0327304.e117"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e117g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e117.jpg"/><mml:math id="M117" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">k</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">T</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> = 4000 of Fig.10 and at the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. LP (static limit point); solid line (stable branch); dashed line (unstable branch). (b) Enlargement of (a).</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g011.jpg"/></fig><p>Next we examine the effect of the fractional effector cell kill <italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub> shown in <xref rid="pone.0327304.g012" ref-type="fig">Fig 12</xref>. Here, the loci of Hopf points forms a maximum and therefore periodic behavior is expected below the maximum. <xref rid="pone.0327304.g013" ref-type="fig">Fig 13</xref> shows an example of behavior for a small value of <italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub>&#8201;=&#8201;10 that represents the case when the drug does not affect much the effector cells. The bifurcation diagram is characterized by the presence of two limit points and a HB point. Stable periodic branches emanate from the Hopf point and terminate as they collide at point (T) with the unstable static branch. It can be seen that drugs intensity below <italic toggle="yes">LP</italic><sub>1</sub> are unable to suppress the tumor. If <italic toggle="yes">v</italic> is increased past <italic toggle="yes">LP</italic><sub>1</sub> but below the point of termination (T), there is bi-stability between the very low tumor cells and the high active tumor cells. Between the termination point (T) and the Hopf point, there is multi-stability between three branches: the very low tumor concentration, the periodic branch and the high tumor branch. Values of drug dose larger than the Hopf point lead to the tumor demise.</p><fig position="float" id="pone.0327304.g012" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g012</object-id><label>Fig 12</label><caption><title>(a) Two parameter continuation diagrams <inline-formula id="pone.0327304.e118"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e118g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e118.jpg"/><mml:math id="M118" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mo mathvariant="bold">,</mml:mo><mml:mi mathvariant="bold-italic">k</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> showing the loci of limit points (solid line) and Hopf point (red line) of <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>.</title><p>(b) Enlargement of (a).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g012.jpg"/></fig><fig position="float" id="pone.0327304.g013" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g013</object-id><label>Fig 13</label><caption><title>Bifurcation diagram for the model with chemotherapy for <inline-formula id="pone.0327304.e119"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e119g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e119.jpg"/><mml:math id="M119" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">k</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">E</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> = 10 of Fig.12 and the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. LP (static limit point); (T) point of collision of periodic branch with the unstable static branch; solid line (stable branch); dashed line (unstable branch); red curve (stable periodic branch).</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g013.jpg"/></fig><p>The effect of the constant <italic toggle="yes">h</italic><sub>2</sub> (<xref rid="pone.0327304.e032" ref-type="disp-formula">Eq 6</xref>) is shown in <xref rid="pone.0327304.g014" ref-type="fig">Fig 14</xref>. It can be seen that static limit points (and hence multiplicity) exist only for values of <italic toggle="yes">h</italic><sub>2</sub> larger than a certain value. We examine the case when <italic toggle="yes">h</italic><sub>2</sub> is zero which implies that the chemotherapy drug has a linear effect on the tumor. <xref rid="pone.0327304.g015" ref-type="fig">Fig 15</xref> shows the bifurcation diagram for this case. No limit or Hopf point are excepted and the digram shows a simple monotonic decline of the tumor with the increase in the chemotherapy dose.</p><fig position="float" id="pone.0327304.g014" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g014</object-id><label>Fig 14</label><caption><title>(a) Two parameter continuation diagrams <inline-formula id="pone.0327304.e120"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e120g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e120.jpg"/><mml:math id="M120" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mo mathvariant="bold">,</mml:mo><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn mathvariant="bold">2</mml:mn></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> showing the loci of limit points (solid line) and Hopf point (red line) of <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g014.jpg"/></fig><fig position="float" id="pone.0327304.g015" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g015</object-id><label>Fig 15</label><caption><title>Bifurcation diagram for the model with chemotherapy for <inline-formula id="pone.0327304.e121"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e121g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e121.jpg"/><mml:math id="M121" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mn mathvariant="bold">2</mml:mn></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> = 0 of</title><p><xref rid="pone.0327304.g014" ref-type="fig">Fig 14</xref> and the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>. Solid line (stable branch).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g015.jpg"/></fig><p>We turn now our attention to the effects of the biological parameters of the model. Two parameters yield additional and novel behavior. <xref rid="pone.0327304.g016" ref-type="fig">Fig 16</xref> shows the effect of <italic toggle="yes">m</italic>, the rate of inactivation of effector cells by the tumor cells. Periodic behavior (red line) can be expected only below a critical value of <italic toggle="yes">m</italic>. <xref rid="pone.0327304.g017" ref-type="fig">Fig 17</xref> shows a sample of behavior for <italic toggle="yes">m</italic>&#8201;=&#8201;0.02. Only two limits points are expected. A classical hysteresis characterizes the behavior of the system. Below <italic toggle="yes">LP</italic><sub>1</sub> the drug is unable to eliminate the tumor. Between <italic toggle="yes">LP</italic><sub>1</sub> and <italic toggle="yes">LP</italic><sub>2</sub> the very low steady state coexists with the high tumor cells. Past <italic toggle="yes">LP</italic><sub>2</sub> the tumor is demised.</p><fig position="float" id="pone.0327304.g016" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g016</object-id><label>Fig 16</label><caption><title>(a) Two parameter continuation diagrams (v,m) showing the loci of limit points (solid line) and Hopf point (red line) of <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>. (b) Enlargement of (a).</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g016.jpg"/></fig><fig position="float" id="pone.0327304.g017" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g017</object-id><label>Fig 17</label><caption><title>Bifurcation diagram for the model with chemotherapy for m = 0.02 of <xref rid="pone.0327304.g016" ref-type="fig">Fig 16</xref> and the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>LP (static limit point); solid line (stable branch); dashed line (unstable branch).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g017.jpg"/></fig><p>The last model parameter to be examined is the recruitment rate (<italic toggle="yes">p</italic>) of the effector cells. <xref rid="pone.0327304.g018" ref-type="fig">Fig 18</xref> shows that Hopf points can exist only for values of <italic toggle="yes">p</italic> smaller than a critical value. The interesting feature of the figure is that for some range of <italic toggle="yes">p</italic> (<xref rid="pone.0327304.g018" ref-type="fig">Fig 18b</xref>) a Hopf point (red curve) exists before a limit point. Moreover, the enlargement in <xref rid="pone.0327304.g018" ref-type="fig">Fig 18c</xref> shows another interesting behavior which is the existence of Hopf points (red curve) without limit points. <xref rid="pone.0327304.g019" ref-type="fig">Fig 19</xref> shows an example of the first behavior for <italic toggle="yes">p</italic>&#8201;=&#8201;20. The diagram is characterized by the presence in this order of a Hopf point, limit point and a limit point. As the drug intensity increases, the tumor cells increase until the Hopf point. Since the branch between the two limit points is unstable, the behavior between Hopf point and the largest limit point (<italic toggle="yes">LP</italic><sub>1</sub>) is characterized by the presence of an oscillatory behavior as the sole outcome of the effector-tumor cells interactions. Values of drug doses larger than <italic toggle="yes">LP</italic><sub>2</sub> causes the tumor to decrease until demise.</p><fig position="float" id="pone.0327304.g018" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g018</object-id><label>Fig 18</label><caption><title>(a) Two parameter continuation diagrams (v,p) showing the loci of limit points (solid line) and Hopf point (red line) of <xref rid="pone.0327304.g006" ref-type="fig">Fig 6</xref>; (b) Enlargement of (a); (c) Enlargement of (a) for the tip of the diagram.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g018.jpg"/></fig><fig position="float" id="pone.0327304.g019" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g019</object-id><label>Fig 19</label><caption><title>Bifurcation diagram for the model with chemotherapy for p = 20 of <xref rid="pone.0327304.g018" ref-type="fig">Fig 18</xref> and the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>LP (static limit point); H (Hopf point); solid line (stable branch); dashed line (unstable branch); red curve (sable periodic branch).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g019.jpg"/></fig><p>An example of the second behavior is shown for <italic toggle="yes">p</italic>&#8201;=&#8201;30 in <xref rid="pone.0327304.g020" ref-type="fig">Fig 20</xref>. In this case two Hopf points are seen to occur and stable branches connect them. Similarly to the previous case of <italic toggle="yes">p</italic>&#8201;=&#8201;20, oscillations are the only outcome between the two Hopf points. All the results of bifurcations found in the model are suitably summarized in <xref rid="pone.0327304.t002" ref-type="table">Table 2</xref>.</p><fig position="float" id="pone.0327304.g020" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.g020</object-id><label>Fig 20</label><caption><title>Bifurcation diagram for the model with chemotherapy for p = 30 of <xref rid="pone.0327304.g018" ref-type="fig">Fig 18</xref> and the dimensionless model parameters in <xref rid="pone.0327304.t001" ref-type="table">Table 1</xref>.</title><p>LP (static limit point); H (Hopf point); solid line (stable branch); dashed line (unstable branch); red curve (sable periodic branch).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="pone.0327304.g020.jpg"/></fig><table-wrap position="float" id="pone.0327304.t002" orientation="portrait"><object-id pub-id-type="doi">10.1371/journal.pone.0327304.t002</object-id><label>Table 2</label><caption><title>Summary of bifurcation behavior found in the diagrams.</title></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.t002g" position="float" orientation="portrait" xlink:href="pone.0327304.t002.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="left" rowspan="1" colspan="1"><xref rid="pone.0327304.g003" ref-type="fig">Fig 3a</xref> and <xref rid="pone.0327304.g003" ref-type="fig">3b</xref></td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">[0,<italic toggle="yes">LP</italic><sub>1</sub>]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e122">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e122g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e122.jpg"/><mml:math id="M122" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e123">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e123g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e123.jpg"/><mml:math id="M123" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(v = 0)</td><td align="left" rowspan="1" colspan="1">(m)</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1">VLT,VHT</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="3" colspan="1">
<xref rid="pone.0327304.g004" ref-type="fig">Fig 4</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">[0,<italic toggle="yes">LP</italic>]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e124">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e124g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e124.jpg"/><mml:math id="M124" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e125">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e125g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e125.jpg"/><mml:math id="M125" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>,</mml:mo><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1.636</mml:mn><mml:mo>,</mml:mo><mml:mn>0.002</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">(m)</td><td align="left" rowspan="1" colspan="1">TF</td><td align="left" rowspan="1" colspan="1">TF,VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e126">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e126g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e126.jpg"/><mml:math id="M126" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>s</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.35</mml:mn><mml:mo>,</mml:mo><mml:mn>0.15</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="2" colspan="1"><xref rid="pone.0327304.g006" ref-type="fig">Figs 6</xref>, <xref rid="pone.0327304.g007" ref-type="fig">7</xref>, <xref rid="pone.0327304.g008" ref-type="fig">8</xref></td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">[0,<italic toggle="yes">LP</italic><sub>1</sub>]</td><td align="left" rowspan="1" colspan="1">[<italic toggle="yes">LP</italic><sub>1</sub>,<italic toggle="yes">LP</italic>2]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e127">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e127g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e127.jpg"/><mml:math id="M127" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e128">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e128g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e128.jpg"/><mml:math id="M128" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e129">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e129g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e129.jpg"/><mml:math id="M129" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e130">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e130g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e130.jpg"/><mml:math id="M130" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e131">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e131g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e131.jpg"/><mml:math id="M131" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1">VLT,MT</td><td align="left" rowspan="1" colspan="1">VT,MT,VHT</td><td align="left" rowspan="1" colspan="1">VLT,P,VHT</td><td align="left" rowspan="1" colspan="1">VLT,MT,VHT</td><td align="left" rowspan="1" colspan="1">VLT,VHT</td><td align="left" rowspan="1" colspan="1">VHT</td></tr><tr><td align="left" rowspan="2" colspan="1">
<xref rid="pone.0327304.g011" ref-type="fig">Fig 11</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">[0,<italic toggle="yes">LP</italic><sub>1</sub>]</td><td align="left" rowspan="1" colspan="1">[<italic toggle="yes">LP</italic><sub>1</sub>,<italic toggle="yes">LP</italic>2]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e132">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e132g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e132.jpg"/><mml:math id="M132" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e133">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e133g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e133.jpg"/><mml:math id="M133" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e134">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e134g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e134.jpg"/><mml:math id="M134" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(<italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>&#8201;=&#8201;4000)</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1">VLT,MT</td><td align="left" rowspan="1" colspan="1">VT,MT,VHT</td><td align="left" rowspan="1" colspan="1">VLT,VHT</td><td align="left" rowspan="1" colspan="1">VHT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="2" colspan="1">
<xref rid="pone.0327304.g013" ref-type="fig">Fig 13</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e135">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e135g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e135.jpg"/><mml:math id="M135" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8804;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">[<italic toggle="yes">LP</italic><sub>1</sub>,<italic toggle="yes">T</italic>]</td><td align="left" rowspan="1" colspan="1">[<italic toggle="yes">T</italic>,<italic toggle="yes">H</italic>]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e136">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e136g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e136.jpg"/><mml:math id="M136" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>H</mml:mi></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(<italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub>&#8201;=&#8201;10)</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VHT</td><td align="left" rowspan="1" colspan="1">VLT,VHT</td><td align="left" rowspan="1" colspan="1">VLT,P,VHT</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="2" colspan="1">
<xref rid="pone.0327304.g017" ref-type="fig">Fig 17</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e137">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e137g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e137.jpg"/><mml:math id="M137" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8804;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e138">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e138g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e138.jpg"/><mml:math id="M138" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e139">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e139g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e139.jpg"/><mml:math id="M139" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e140">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e140g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e140.jpg"/><mml:math id="M140" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>0.02</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VHT</td><td align="left" rowspan="1" colspan="1">VLT,VHT</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="2" colspan="1">
<xref rid="pone.0327304.g019" ref-type="fig">Fig 19</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e141">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e141g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e141.jpg"/><mml:math id="M141" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8804;</mml:mo><mml:mi>H</mml:mi></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">[<italic toggle="yes">H</italic>,<italic toggle="yes">LP</italic><sub>1</sub>]</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e142">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e142g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e142.jpg"/><mml:math id="M142" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:mi>L</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e143">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e143g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e143.jpg"/><mml:math id="M143" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>20</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="2" colspan="1">
<xref rid="pone.0327304.g020" ref-type="fig">Fig 20</xref>
</td><td align="left" rowspan="1" colspan="1">Key par.</td><td align="left" rowspan="1" colspan="1">Bif. par.</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e144">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e144g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e144.jpg"/><mml:math id="M144" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8804;</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e145">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e145g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e145.jpg"/><mml:math id="M145" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e146">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e146g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e146.jpg"/><mml:math id="M146" display="inline" overflow="scroll"><mml:mrow><mml:mo>&#8805;</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<inline-formula id="pone.0327304.e147">
<alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e147g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e147.jpg"/><mml:math id="M147" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>30</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives>
</inline-formula>
</td><td align="left" rowspan="1" colspan="1">(v)</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">VLT</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p><bold>Notes:</bold> Bif. par.: Bifurcation parameter in the figure (x-axis).</p><p>Key par.: All model parameter&#8217;s value are taken from Table (1), expect the value of the key parameter associated with the figure.</p><p>MT: Medium tumor levels.</p><p>P: periodic behavior.</p><p>TF: Tumor-free equilibrium.</p><p>VLT: Very low tumor levels .</p><p>VHT: Very high tumor levels.</p><p>&#8201; [&#8211;,&#8211;]: Range of the bifurcation parameter.</p><p>X,Y: Indicates the coexistence of equilibria X and Y.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="sec012"><title>7 Discussion and biological implications</title><p>In the absence of chemotherapy treatment, the model with von Bertalanffy&#8217;s growth rate can predict some similar outcomes to the ones with the logistic growth model e.g. slight changes in model parameters can induce bi-stability in form of hysteresis. In actual circumstances, variations in parameter values are feasible as both effector and tumor cell populations are not uniform. Distinct subpopulations within these groups possess unique parameter values that influence their behavior. The model was shown to predict, similarly to the logistic growth, tumor dormancy and escape from immuno-regulation through a hysteresis bifurcation. However, there is a fundamental difference between the logistic growth and the von Bertalanffy&#8217; model. In the former case, the tumor-free equilibrium can be stablized by change in some of the model parameters, through for instance, immunotherapy that can enhance the cytolytic potential of effector cells [<xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0327304.ref012" ref-type="bibr">12</xref>] (parameter (m) in <xref rid="pone.0327304.e005" ref-type="disp-formula">Eq 1</xref>). This is not the case for von Bertalnaffy&#8217;s model where the tumor-free disease is always unstable and the best outcome that could be predicted by the model is a very low tumor concentration steady state. Bistability was found to be accentuated by an increase in effector growth rate, a decrease in effect death rate, an increase in recruitment rate of effector cells and a decrease in the inactivation rate of effector cells.</p><p>For a bistable system, the location of the basin boundary is important in determining the outcome of the disease. Any treatment&#8217;s goal should be to move the system into the basin of attraction of the targeted equilibrium state. In the absence of chemotherapy, this goal can be attained by diminishing the tumor cell count through surgical techniques or radiation, and/or by augmenting the immune cell levels through adoptive cell transfer [<xref rid="pone.0327304.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0327304.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0327304.ref021" ref-type="bibr">21</xref>].</p><p>The model, in the absence of chemotherapy, was shown to be unable to predict an oscillatory behavior characterized by the continuous pursuit of competing cells. The findings reveal that the proposed model cannot predict periodic behavior for any set of parameter values. We even extended this result to other tumor growth rates expressions. It is &#8220;normally&#8221; advantageous for tumor cells to instigate fluctuations in the human body as this can lead to a temporary suppression of the immune system and an increased rate of tumor propagation [<xref rid="pone.0327304.ref024" ref-type="bibr">24</xref>]. This was clearly verified in some diseases such as malaria [<xref rid="pone.0327304.ref034" ref-type="bibr">34</xref>]. However, oscillatory behavior has not been confirmed in interactions between tumors and immune cells [<xref rid="pone.0327304.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0327304.ref035" ref-type="bibr">35</xref>] at least in the absence of chemotherapy. A plausible explanation is the possible risk of autoimmune reactions that may damage healthy cells. Therefore the lack of oscillations in the studied model, in the absence of chemotherapy, does not lower its quality despite its obvious simplicity.</p><p>The introduction of chemotherapy treatment, as external agent to the tumor-immune system, added considerable complexity to the types of behavior the model can predict. The complex interplay between the biological parameters of the model and the chemotherapy parameters can lead to a number of scenarios. Low doses of chemotherapy do not effectively suppress high tumor cell counts, while very high doses can result in tumor demise. When the drug intensity is situated between low and high levels, multi-stability is observed, characterized not only by hysteresis (coexistence of two stable steady states) but also multiple stable steady-states. In this latter instance, initial conditions or a temporarily weakened immune system can facilitate a transition from a very low tumor cell steady state to a medium steady state, circumventing a direct transition to the highest state. It should be noted that bi-stability/multi-stability may not be avoided in real situations since these phenomena were found to occur at small to moderate drug doses i.e. when the dimensionless drug dose was less than approximately 0.1, which corresponds to value of <inline-formula id="pone.0327304.e148"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e148g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e148.jpg"/><mml:math id="M148" display="inline" overflow="scroll"><mml:mrow><mml:mn>100</mml:mn><mml:mtext>&#160;</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> per day, a value well within guidelines of most chemotherapy drugs [<xref rid="pone.0327304.ref031" ref-type="bibr">31</xref>]. Therefore even with chemotherapy placing the patient through the right basin boundary is critical to avoid re-growth of tumor. This could be achieved if immunotherapy is administered to a patient after chemotherapy which will cause the effector levels to increase allowing the system to move towards the intended equilibrium.</p><p>Moreover, the model predicted that the administration of chemotherapy can trigger oscillations. For some model parameters, the oscillations coexist with the static branches while in other situations and for some range of chemotherapy drug they are the only outcomes of the treatment. These oscillations are certainly unwanted and can cause harm to other body functions therefore they should be avoided, either by moving the drug dose outside the unwanted range or by placing the system in the right basin of attractions. The range of the oscillatory behavior was found to be reduced with the increase in the tumor cells lysis rate <italic toggle="yes">m</italic>, the recruitment rate <italic toggle="yes">p</italic> of effector cells, and fractional tumor kill cells <italic toggle="yes">k</italic><sub><italic toggle="yes">T</italic></sub>. On the other hand, the range of oscillations decreases with increase in <italic toggle="yes">k</italic><sub><italic toggle="yes">E</italic></sub> and/or <italic toggle="yes">h</italic><sub>2</sub>.</p><p>Furthermore, we established a significant finding: the inclusion of a saturation parameters (<italic toggle="yes">h</italic><sub>1</sub>) and (<italic toggle="yes">h</italic><sub>2</sub>) in the chemotherapy term <inline-formula id="pone.0327304.e149"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e149g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e149.jpg"/><mml:math id="M149" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:mi>E</mml:mi><mml:mo>/</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>E</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> or in the tumor <inline-formula id="pone.0327304.e150"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e150g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e150.jpg"/><mml:math id="M150" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:mi>T</mml:mi><mml:mo>/</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>T</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> term is essential for the emergence of such oscillations. A linear effect <inline-formula id="pone.0327304.e151"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e151g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e151.jpg"/><mml:math id="M151" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>E</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> or <inline-formula id="pone.0327304.e152"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e152g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e152.jpg"/><mml:math id="M152" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mi>T</mml:mi></mml:msub><mml:mi>v</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> (i.e. <inline-formula id="pone.0327304.e153"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e153g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e153.jpg"/><mml:math id="M153" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>) does not produce any oscillatory behavior across any model parameters. Consequently, the oscillations are attributed not only to the presence of the chemotherapy agent <inline-formula id="pone.0327304.e154"><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="pone.0327304.e154g" position="anchor" orientation="portrait" xlink:href="pone.0327304.e154.jpg"/><mml:math id="M154" display="inline" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>v</mml:mi><mml:mo>&#8800;</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula> but also to its type of impact on the reduction of tumor cells. Specifically, if the rates of effector and tumor cell reduction is directly proportional to the drug intensity, oscillations will not occur for any model parameter&#8217;s values.</p><p>A final note should be made about the limitations of this work. The model is certainly the simplest model that could be used to explain tumor-immune cells interactions. But out analysis has shown that this simple and classical model has quite a lot of blood in it. Furthermore, although the model parameters were taken from experimental settings, some of the found behavior associated with the chemotherapy needs to be validated against real life outcomes. Also in real life the effect of chemotherapy drug is not direct and includes some sort of delay. Including such delay in the expressions of the effects of chemotherapy will deserve further study.</p></sec><sec id="sec013" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0327304.s001" position="float" content-type="local-data" orientation="portrait"><label>Appendix A</label><caption><title>Coefficients of polynomial of <xref rid="pone.0327304.e069" ref-type="disp-formula">Eq 8</xref></title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0327304.s001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pone.0327304.s002" position="float" content-type="local-data" orientation="portrait"><label>Appendix B</label><caption><title>Proof of Hopf points for arbitrary tumor growth rate.</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0327304.s002.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pone.0327304.s003" position="float" content-type="local-data" orientation="portrait"><label>Appendix C</label><caption><title>Proof of stability of disease-free equilibrium for logistic growth.</title><p>(PDF)</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pone.0327304.s003.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0327304.ref001"><label>1</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Laversanne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. <year>2024</year>;<volume>74</volume>(<issue>3</issue>):<fpage>229</fpage>&#8211;<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id><pub-id pub-id-type="pmid">38572751</pub-id></mixed-citation></ref><ref id="pone.0327304.ref002"><label>2</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Raghani</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Chorawala</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Mahadik</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Prajapati</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Parekh</surname><given-names>PS</given-names></name>. <article-title>Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies</article-title>. <source>Med Oncol</source>. <year>2024</year>;<volume>41</volume>(<issue>2</issue>):<fpage>51</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12032-023-02280-7</pub-id><pub-id pub-id-type="pmid">38195781</pub-id></mixed-citation></ref><ref id="pone.0327304.ref003"><label>3</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Siu</surname><given-names>KTH</given-names></name>, <name name-style="western"><surname>Guan</surname><given-names>X-Y</given-names></name>. <article-title>Exploring treatment options in cancer: Tumor treatment strategies</article-title>. <source>Signal Transduct Target Ther</source>. <year>2024</year>;<volume>9</volume>(<issue>1</issue>):<fpage>175</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41392-024-01856-7</pub-id><pub-id pub-id-type="pmid">39013849</pub-id><pub-id pub-id-type="pmcid">PMC11252281</pub-id></mixed-citation></ref><ref id="pone.0327304.ref004"><label>4</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Murphy</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Jaafari</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dobrovolny</surname><given-names>HM</given-names></name>. <article-title>Differences in predictions of ODE models of tumor growth: a cautionary example</article-title>. <source>BMC Cancer</source>. <year>2016</year>;<volume>16</volume>:<fpage>163</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12885-016-2164-x</pub-id><pub-id pub-id-type="pmid">26921070</pub-id><pub-id pub-id-type="pmcid">PMC4768423</pub-id></mixed-citation></ref><ref id="pone.0327304.ref005"><label>5</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ghaffari Laleh</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Loeffler</surname><given-names>CML</given-names></name>, <name name-style="western"><surname>Grajek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sta&#328;kov&#225;</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pearson</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Muti</surname><given-names>HS</given-names></name>, <etal>et al</etal>. <article-title>Classical mathematical models for prediction of response to chemotherapy and immunotherapy</article-title>. <source>PLoS Comput Biol</source>. <year>2022</year>;<volume>18</volume>(<issue>2</issue>):e1009822. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009822</pub-id><pub-id pub-id-type="pmid">35120124</pub-id><pub-id pub-id-type="pmcid">PMC8903251</pub-id></mixed-citation></ref><ref id="pone.0327304.ref006"><label>6</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mathur</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Scher</surname><given-names>HI</given-names></name>, <name name-style="western"><surname>Xavier</surname><given-names>JB</given-names></name>. <article-title>Optimizing the future: how mathematical models inform treatment schedules for cancer</article-title>. <source>Trends Cancer</source>. <year>2022</year>;<volume>8</volume>(<issue>6</issue>):<fpage>506</fpage>&#8211;<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.trecan.2022.02.005</pub-id><pub-id pub-id-type="pmid">35277375</pub-id><pub-id pub-id-type="pmcid">PMC9117454</pub-id></mixed-citation></ref><ref id="pone.0327304.ref007"><label>7</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Craig</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jenner</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Namgung</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>Goldman</surname><given-names>A</given-names></name>. <article-title>Engineering in medicine to address the challenge of cancer drug resistance: from micro- and nanotechnologies to computational and mathematical modeling</article-title>. <source>Chem Rev</source>. <year>2021</year>;<volume>121</volume>(<issue>6</issue>):<fpage>3352</fpage>&#8211;<lpage>89</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.chemrev.0c00356</pub-id><pub-id pub-id-type="pmid">33152247</pub-id></mixed-citation></ref><ref id="pone.0327304.ref008"><label>8</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brady</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Enderling</surname><given-names>H</given-names></name>. <article-title>Mathematical models of cancer: when to predict novel therapies, and when not to</article-title>. <source>Bull Math Biol</source>. <year>2019</year>;<volume>81</volume>(<issue>10</issue>):<fpage>3722</fpage>&#8211;<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11538-019-00640-x</pub-id><pub-id pub-id-type="pmid">31338741</pub-id><pub-id pub-id-type="pmcid">PMC6764933</pub-id></mixed-citation></ref><ref id="pone.0327304.ref009"><label>9</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kuznetsov</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Makalkin</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Perelson</surname><given-names>AS</given-names></name>. <article-title>Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis</article-title>. <source>Bull Math Biol</source>. <year>1994</year>;<volume>56</volume>(<issue>2</issue>):<fpage>295</fpage>&#8211;<lpage>321</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF02460644</pub-id><pub-id pub-id-type="pmid">8186756</pub-id></mixed-citation></ref><ref id="pone.0327304.ref010"><label>10</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Matzavinos</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chaplain</surname><given-names>MAJ</given-names></name>, <name name-style="western"><surname>Kuznetsov</surname><given-names>VA</given-names></name>. <article-title>Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour</article-title>. <source>Math Med Biol</source>. <year>2004</year>;<volume>21</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/imammb/21.1.1</pub-id><pub-id pub-id-type="pmid">15065736</pub-id></mixed-citation></ref><ref id="pone.0327304.ref011"><label>11</label><mixed-citation publication-type="journal"><name name-style="western"><surname>de Pillis</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Radunskaya</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Wiseman</surname><given-names>CL</given-names></name>. <article-title>A validated mathematical model of cell mediated immune response to tumor growth</article-title>. <source>Cancer Res</source>. <year>2005</year>;<volume>65</volume>(<issue>17</issue>):<fpage>7950</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16140967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-05-0564</pub-id></mixed-citation></ref><ref id="pone.0327304.ref012"><label>12</label><mixed-citation publication-type="journal"><name name-style="western"><surname>de Pillis</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Radunskaya</surname><given-names>AE</given-names></name>. <article-title>Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations</article-title>. <source>J Theor Biol</source>. <year>2006</year>;<volume>238</volume>(<issue>4</issue>):<fpage>841</fpage>&#8211;<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jtbi.2005.06.037</pub-id><pub-id pub-id-type="pmid">16153659</pub-id></mixed-citation></ref><ref id="pone.0327304.ref013"><label>13</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Al-Tameemi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chaplain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>d&#8217;Onofrio</surname><given-names>A</given-names></name>. <article-title>Evasion of tumours from the control of the immune system: consequences of brief encounters</article-title>. <source>Biol Direct</source>. <year>2012</year>;<volume>7</volume>:<fpage>31</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1745-6150-7-31</pub-id><pub-id pub-id-type="pmid">23009638</pub-id><pub-id pub-id-type="pmcid">PMC3582466</pub-id></mixed-citation></ref><ref id="pone.0327304.ref014"><label>14</label><mixed-citation publication-type="journal"><name name-style="western"><surname>L&#243;pez</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Seoane</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sanju&#225;n</surname><given-names>MAF</given-names></name>. <article-title>A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy</article-title>. <source>Bull Math Biol</source>. <year>2014</year>;<volume>76</volume>(<issue>11</issue>):<fpage>2884</fpage>&#8211;<lpage>906</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s11538-014-0037-5</pub-id><pub-id pub-id-type="pmid">25348062</pub-id></mixed-citation></ref><ref id="pone.0327304.ref015"><label>15</label><mixed-citation publication-type="confproc"><name name-style="western"><surname>Lestari</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sari</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Arifah</surname><given-names>H</given-names></name>. <conf-name>Dynamics of a mathematical model of cancer cells with chemotherapy</conf-name>. <conf-name>J Phys Conf. Ser.</conf-name><year>2019</year>.</mixed-citation></ref><ref id="pone.0327304.ref016"><label>16</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Makhlouf</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>El-Shennawy</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Elkaranshawy</surname><given-names>HA</given-names></name>. <article-title>Mathematical modelling for the role of CD4+T cells in tumor-immune interactions</article-title>. <source>Comput Math Methods Med</source>. <year>2020</year>;<volume>2020</volume>:<fpage>7187602</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2020/7187602</pub-id><pub-id pub-id-type="pmid">32148558</pub-id><pub-id pub-id-type="pmcid">PMC7049850</pub-id></mixed-citation></ref><ref id="pone.0327304.ref017"><label>17</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rihan</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Rajivganthi</surname><given-names>C</given-names></name>. <article-title>Dynamics of tumor-immune system with random noise</article-title>. <source>Mathematics</source>. <year>2021</year>;<volume>9</volume>(<issue>21</issue>):<fpage>2707</fpage>.</mixed-citation></ref><ref id="pone.0327304.ref018"><label>18</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Das</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dehingia</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sarmah</surname><given-names>HK</given-names></name>. <article-title>Stability analysis of a targeted chemotherapy-cancer model</article-title>. <source>Math Model Control</source>. <year>2023</year>;<volume>3</volume>(<issue>2</issue>):<fpage>116</fpage>&#8211;<lpage>26</lpage>.</mixed-citation></ref><ref id="pone.0327304.ref019"><label>19</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mirzaei N</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tatarova</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Changizi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Asadpoure</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zervantonakis</surname><given-names>IK</given-names></name>, <etal>et al</etal>. <article-title>APDE model of breast tumor progression in MMTV-PyMT Mice</article-title>. <source>J Pers Med</source>. <year>2022</year>;<volume>9</volume>(<issue>12</issue>):<fpage>938</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jpm12050807</pub-id><pub-id pub-id-type="pmcid">PMC9145520</pub-id><pub-id pub-id-type="pmid">35629230</pub-id></mixed-citation></ref><ref id="pone.0327304.ref020"><label>20</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bashkirtseva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Chukhareva</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ryashko</surname><given-names>L</given-names></name>. <article-title>Modeling and analysis of nonlinear tumor-immune interaction under chemotherapy and radiotherapy</article-title>. <source>Math Meth Appl Sci</source>. <year>2022</year>;<volume>12</volume>(<issue>5</issue>):<fpage>807</fpage>.</mixed-citation></ref><ref id="pone.0327304.ref021"><label>21</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Song</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>. <article-title>Mathematical modeling and analysis of tumor chemotherapy</article-title>. <source>Symmetry</source>. <year>2022</year>;<volume>14</volume>(<issue>4</issue>):<fpage>704</fpage>.</mixed-citation></ref><ref id="pone.0327304.ref022"><label>22</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feng</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>D</given-names></name>. <article-title>Dynamics and stability of a fractional-order tumor-immune interaction model with B-D functional response and immunotherapy</article-title>. <source>Fractal Fract</source>. <year>2023</year>;<volume>7</volume>(<issue>2</issue>):<fpage>200</fpage>.</mixed-citation></ref><ref id="pone.0327304.ref023"><label>23</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Azizi</surname><given-names>T</given-names></name>. <article-title>Mathematical modeling of cancer progression</article-title>. <source>Appl Math</source>. <year>2024</year>;<volume>4</volume>(<issue>3</issue>):<fpage>1065</fpage>&#8211;<lpage>79</lpage>.</mixed-citation></ref><ref id="pone.0327304.ref024"><label>24</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kareva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Luddy</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>O&#8217;Farrelly</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gatenby</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>JS</given-names></name>. <article-title>Predator-prey in tumor-immune interactions: a wrong model or just an incomplete one?</article-title><source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<fpage>668221</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2021.668221</pub-id><pub-id pub-id-type="pmid">34531851</pub-id><pub-id pub-id-type="pmcid">PMC8438324</pub-id></mixed-citation></ref><ref id="pone.0327304.ref025"><label>25</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Von Bertalanffy</surname><given-names>L</given-names></name>. <article-title>Quantitative laws in metabolism and growth</article-title>. <source>Q Rev Biol</source>. <year>1957</year>;<volume>32</volume>(<issue>3</issue>):<fpage>217</fpage>&#8211;<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/401873</pub-id><pub-id pub-id-type="pmid">13485376</pub-id></mixed-citation></ref><ref id="pone.0327304.ref026"><label>26</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vaidya</surname><given-names>VG</given-names></name>, <name name-style="western"><surname>Alexandro FJ</surname><given-names>Jr</given-names></name>. <article-title>Evaluation of some mathematical models for tumor growth</article-title>. <source>Int J Biomed Comput</source>. <year>1982</year>;<volume>13</volume>(<issue>1</issue>):<fpage>19</fpage>&#8211;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0020-7101(82)90048-4</pub-id><pub-id pub-id-type="pmid">7061168</pub-id></mixed-citation></ref><ref id="pone.0327304.ref027"><label>27</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Heesterman</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Bokhorst</surname><given-names>J-M</given-names></name>, <name name-style="western"><surname>de Pont</surname><given-names>LMH</given-names></name>, <name name-style="western"><surname>Verbist</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Bayley</surname><given-names>J-P</given-names></name>, <name name-style="western"><surname>van der Mey</surname><given-names>AGL</given-names></name>, <etal>et al</etal>. <article-title>Mathematical models for tumor growth and the reduction of overtreatment</article-title>. <source>J Neurol Surg B Skull Base</source>. <year>2019</year>;<volume>80</volume>(<issue>1</issue>):<fpage>72</fpage>&#8211;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1055/s-0038-1667148</pub-id><pub-id pub-id-type="pmid">30733904</pub-id><pub-id pub-id-type="pmcid">PMC6365230</pub-id></mixed-citation></ref><ref id="pone.0327304.ref028"><label>28</label><mixed-citation publication-type="journal"><name name-style="western"><surname>K&#252;hleitner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brunner</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>W-G</given-names></name>, <name name-style="western"><surname>Renner-Martin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Scheicher</surname><given-names>K</given-names></name>. <article-title>Best fitting tumor growth models of the von Bertalanffy-P&#252;tterType</article-title>. <source>BMC Cancer</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>683</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12885-019-5911-y</pub-id><pub-id pub-id-type="pmid">31299926</pub-id><pub-id pub-id-type="pmcid">PMC6624893</pub-id></mixed-citation></ref><ref id="pone.0327304.ref029"><label>29</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gardner</surname><given-names>SN</given-names></name>. <article-title>Amechanistic, predictive model of dose-response curves for cell cycle phase specific and nonspecific drugs</article-title>. <source>Cancer Res</source>. <year>2000</year>;<volume>60</volume>(<issue>5</issue>):<fpage>1417</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">10728708</pub-id></mixed-citation></ref><ref id="pone.0327304.ref030"><label>30</label><mixed-citation publication-type="book"><source>MATLAB</source>. Version 9.4.0 (R2018a), <publisher-loc>Natick, MA, USA</publisher-loc>: <publisher-name>The MathWorks Inc.</publisher-name><year>2018</year>.</mixed-citation></ref><ref id="pone.0327304.ref031"><label>31</label><mixed-citation publication-type="other">McDonnell AM. Chemotherapeutic agents and their uses, dosages, and toxicities. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cancernetwork.com/view/chemotherapeutic-agents-and-their-uses-dosages-and-toxicities" ext-link-type="uri">https://www.cancernetwork.com/view/chemotherapeutic-agents-and-their-uses-dosages-and-toxicities</ext-link>. Accessed 2025 April 1.</mixed-citation></ref><ref id="pone.0327304.ref032"><label>32</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dhooge</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Govaerts</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kuznetsov</surname><given-names>YA</given-names></name>. <article-title>New features of the software MatCont for bifurcation analysis of dynamical systems</article-title>. <source>Math Comput Model Dyn Syst</source>. <year>2008</year>;<volume>14</volume>(<issue>2</issue>):<fpage>147</fpage>&#8211;<lpage>75</lpage>.</mixed-citation></ref><ref id="pone.0327304.ref033"><label>33</label><mixed-citation publication-type="book"><name name-style="western"><surname>Wiggins</surname><given-names>S</given-names></name>. <source>Introduction to applied nonlinear dynamical systems and chaos</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>. <year>1980</year>.</mixed-citation></ref><ref id="pone.0327304.ref034"><label>34</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Smith</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Motta</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Chopra</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Moch</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Nerem</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Cummins</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>An intrinsic oscillator drives the blood stage cycle of the malaria parasite Plasmodium falciparum</article-title>. <source>Science</source>. <year>2020</year>;<volume>368</volume>(<issue>6492</issue>):<fpage>754</fpage>&#8211;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.aba4357</pub-id><pub-id pub-id-type="pmid">32409472</pub-id><pub-id pub-id-type="pmcid">PMC7518718</pub-id></mixed-citation></ref><ref id="pone.0327304.ref035"><label>35</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dorraki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fouladzadeh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Salamon</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Allison</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Coventry</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Abbott</surname><given-names>D</given-names></name>. <article-title>On detection of periodicity in C-reactive protein (CRP) levels</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>11979</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-30469-8</pub-id><pub-id pub-id-type="pmid">30097610</pub-id><pub-id pub-id-type="pmcid">PMC6086826</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>